Why it fits
Precision fermentation platform for alternative dairy proteins, directly targeting the fund's core thesis in food systems transformation.
Pre-seed, raising a first institutional round of about 3 M EUR against an 18-month pilot plan.
Two of three founders led the strain-engineering group at Novonesis before spinning out in 2025.
What needs validation
No named paying customers identified, so commercial traction is unverified.
Bioreactor cost per kilo is not disclosed anywhere in public material.
EU novel food approval for the lead protein has not been filed.